Safe Carrier Research Articles

A novel chitosan microsphere as food processing enzyme immobilization carrier and its application in nucleotide production.

Developing a robust and safe carrier for enzyme immobilization is crucial for their application in the food processing industry. In this study, a novel crosslinked chitosan microspheres (CSMs) were prepared using glutaraldehyde (GA) as the crosslinking agent, using a newly developed emulsification-neutralization combined method. Nuclease P1 (NP1) was immobilized onto these microspheres, the maximum activity of NP1@CSMs-GA reach to 53,859.4U/g. The activity recovery yield reach to 75%. Compared to the free NP1, the stability of NP1@CSMs-GA was significantly enhanced. Its vmax and Km is 895.71mg/(g·min) and 77.27mg/mL respectively. This NP1@CSMs-GA was utilized in production of nucleotides through hydrolysis of RNA. In BSTR, NP1@CSMs-GA retained more than 75.1% initial activity after 10cycles of reuse. Moreover, in PBR, the RNA hydrolysis conversion rate maintained 81% after 24h of continuous operation. These results demonstrate that NP1@CSMs-GA exhibits excellent reusability and production stability in practical processes.

Hyaluronic Acid-Based pH-Sensitive Nanogel: Synthesis, Characterization, and Assessment for Acyclovir Delivery In Vitro and In Vivo.

Acyclovir (ACV) is a potentially effective antiviral medication; however, it has a serious drawback, which is its poor solubility, bioavailability, and short half-life. The goal of this study is to improve its drawbacks through the synthesis of nanogels. In this study, the cross-linked hyaluronic acid-grafted poly(acrylamide-co-itaconic acid) nanogel is synthesized successfully through free radical polymerization and used as a safe pH-responsive carrier for ACV. The nanogels showed pH response in vitro and in vivo. The prepared nanogel C5 (1:1 ratio of acrylamide: itaconic), which had the highest grafting efficiency, showed maximum swelling, drug loading, and release in pH 7.4, higher than pH 1.2. Also, nanogel C5, which had a large surface area, showed good stability, and its matrices shrank in acidic medium and protected the drug, while in basic medium, it expanded and released ACV in a sustained manner and improved the bioavailability and half-life of ACV in vivo.

Comparative Study of Functionalized Carbosilane Dendrimers for siRNA Delivery: Synthesis, Cytotoxicity, and Biophysical Properties.

Efficient and safe carriers of genetic material are crucial for advancing gene therapy. Three new series of cationic dendritic nanocarriers based on a carbosilane scaffold, differentiated by peripheral modifications: saccharide (CS-glyco), amine (CS-N), and phosphonium dendrimers (CS-P) were designed for binding, protecting, and releasing polyanionic compounds like therapeutic siRNA. Besides introducing synthetic methodology, this study brings a unique direct interstructural comparison of 16 dendritic nanovector's characteristics, addressing a gap in typical research that focuses on uniform structural types. The study evaluates the dendrimer's in vitro cytotoxicity, biophysical properties, and complexation capabilities in comparison with widely used PAMAM dendrimers. CS-glyco and PAMAMs were significantly less toxic to MCF-7 and THP-1 cell lines than were CS-N and CS-P, despite having the same peripheral charge density. Notably, CS-glyco maintained biocompatibility comparable to analogous neutral CS glycodendrimers, underscoring the exceptional capability of sugar coating to reduce toxicity. Dendriplexes formed from these nanocarriers protected siRNA from RNase degradation and facilitated its release in the presence of heparin, highlighting its potential in gene delivery applications. The study provides a background for future in-depth investigations into the introduced dendritic nanocarriers, which show significant potential for advancing drug delivery.

Development of metal-organic framework biocomposites from chitosan as drug delivery vehicles: In vitro evaluation on HeLa and SH-SY5Y cell lines.

In modern times, achieving precise drug delivery through a safe and stable carrier remains a significant challenge. In this study, we synthesized a novel ligand based on a guanazole Schiff base and subsequently developed new metal-organic framework (MOF) named UWO-1 through a reaction involving zinc acetate. At the same time, curcumin (CUR) was loaded onto the newly synthesized UWO-1. The formation of UWO-1 and CUR loading were confirmed through various spectral analyses, including FT-IR, SEM, PXRD, XPS, TGA, zeta potential, DLS, and BET. The specific BET surface area of the UWO-1 is approximately 1456.50 m2/g. The resulting drug delivery system exhibited a drug loading of 30.7 % and an encapsulation efficiency of 94.9 %. CUR@UWO-1 demonstrated rapid drug release, leading to the application of a chitosan (CS) coating to achieve controlled and delayed intravenous delivery, resulting in the creation of CS/CUR@UWO-1 biocomposite microspheres. The cumulative release profile of CUR from CS/CUR@UWO-1 was evaluated in phosphate-buffered saline (PBS) at pH 5.0 and 7.4 over 18 h, revealing release percentages of 66.99 % and 47.18 %, respectively. The release kinetics were studied and found to closely follow the Higuchi model, which was determined to be the best fit. Furthermore, the material's cytotoxicity and anticancer activity were assessed by measuring mitochondrial metabolic activity in vitro. Additionally, this nanosystem was able to internalize the drug into the cells. The combined advantages of enhanced drug loading and sustained pH-responsive release highlight the potential of the MOF-based biocomposite as a versatile drug delivery system for therapeutic applications.

Modified PEG-Lipids Enhance the Nasal Mucosal Immune Capacity of Lipid Nanoparticle mRNA Vaccines.

Omicron, the predominant variant of SARS-CoV-2, exhibits strong immune-evasive properties, leading to the reduced efficacy of existing vaccines. Consequently, the development of versatile vaccines is imperative. Intranasal mRNA vaccines offer convenient administration and have the potential to enhance mucosal immunity. However, delivering vaccines via the nasal mucosa requires overcoming complex physiological barriers. The aim of this study is to modify PEGylated lipids to enhance the mucosal immune efficacy of the vaccine. The PEGylated lipid component of lipid nanoparticle (LNP) delivery vectors was modified with chitosan or mannose to generate novel LNPs that enhance vaccine adhesion or targeting on mucosal surfaces. The impact of the mRNA encoding the receptor-binding domain of Omicron BA.4/BA.5 on the immune response was examined. Compared to the unmodified LNP group, the IgG and IgA titers in the chitosan or mannose-modified LNP groups showed an increasing trend. The chitosan-modified group showed better effects. Notably, the PEGylated lipid with 1.5 mol% of chitosan modification produced high levels of IgG1 and IgG2a antibodies, promoting Th1/Th2 responses while also generating high levels of IgA, which can induce stronger cellular immunity, humoral immunity, and mucosal immunity. The 1.5 mol% of chitosan-modified LNPs (mRNA-LNP-1.5CS) can serve as a safe and effective carrier for intranasal mRNA vaccines, offering a promising strategy for combating the Omicron variant.

Fragrance Carrier Based on Zeolite-A Modified Bentonite as a Controlled Release System in Air Freshener Applications

The quality of air fresheners with low cost production can be improved by using a carrier matrix such as synthetic zeolite to increase the long-lasting properties of fragrance product by encapsulation technique. The zeolite A is considerdas a safe core fragrance carrier matrix to be able to release volatile fragrance from their pores when exposed to atmospheric humidity at room temperature. Zeolite A was synthesized from natural kaolin and was formed into tube pellets with bentonite (20 wt.%) as binder to produce zeolite A-bentonite (ZAB) cylindrical pellets composite and used as a fragrance carrier matrix with a rose essential oil (Rose damascena Mill.) as parfume model. The fresh bentonite can also adsorb the rose essential oil with adsorption capacity of 1.745 g/g bentonite (74.5%). Effects of chemical activation on zeolite-A using acid (HCl) of 0.1 M and base (NaOH) of 0.1 M were studied. The ZAB tube pelletes were found to have high adsorption efficiencies of rose essential oil. ZAB4 has the highest efficiency and was used for regeneration test studies that was carried out over 10 cycles using HCl and NaOH, where the adsorption efficiency was 94.5 and 75.4%, respectively. The activated ZAB4 composite using HCl has a long life time until more than 5 weeks and more than 10 regeneration cycles. This fragrance carrier matrix based on ZAB has significant potential for extended carrier fragrance system.

Intranasal liposomal angiotensin-(1-7) administration reduces inflammation and viral load in the lungs during SARS-CoV-2 infection in K18-hACE2 transgenic mice.

To effectively reduce the health impact of coronavirus disease (COVID-19), it is essential to adopt comprehensive strategies to protect individuals from severe acute respiratory syndrome. In that sense, much effort has been devoted to the discovery and repurposing of effective antiviral and anti-inflammatory molecules. The endogenous peptide angiotensin-(1-7) [Ang-(1-7)] has been recently proposed as a promising anti-inflammatory agent to control respiratory infections. Liposomes also emerged as a safe and effective drug carrier system for local drug delivery to the lungs. In this context, the aim of this study was to develop a liposomal formulation of Ang-(1-7) [LAng (1-7)] and investigate its impact on animal survival as well as its antiviral and anti-inflammatory efficacies after intranasal administration in transgenic K18-hACE2 mice infected with SARS-CoV-2. The liposomal formulation was prepared by the ethanol injection method, exhibiting a mean diameter of 100 nm and a polydispersity index of 0.1. Following treatment of infected mice every 12 hours for 5 days, LAng (1-7) extended animal survival compared to the control groups that received either empty liposomes, free Ang-(1-7), or phosphate-buffered saline. Furthermore, the treatment with LAng (1-7) significantly decreased the viral load, as well as IL-6 and tumor necrosis factor levels in the lungs. Conventional treatment with remdesivir by parenteral route used as a positive control promoted similar effects, leading to improved survival rates and reduced viral load in the lungs without significant effects on IL-6 level. In conclusion, liposomal Ang-(1-7) emerges as a promising formulation to improve the treatment and decrease the severity of respiratory infections, such as COVID-19.

Bone-targeted ultrasound-responsive nanobubbles for siRNA delivery to treat osteoporosis in mice

This project aimed to study the efficacy of a bone-targeted ultrasound-responsive nanobubble (NB) platform to deliver gene-silencing cathepsin K (CTSK) siRNA into the bone for osteoporosis treatment using in vitro and in vivo studies. To this end, characterization of CTSK siRNA loaded NB functionalized with alendronate (NB-CTSK siRNA-AL) was performed using transmission electron microscopy (TEM) imaging, and a release profile was obtained through fluorescent spectroscopy. In vitro studies were conducted by culturing NB-CTSK siRNA-AL with osteoclasts to evaluate siRNA uptake, CTSK expression, and the expression of tartrate-resistant acid phosphatase (TRAP). A control group and an NB-CTSK siRNA-AL treated group of ovariectomized (OVX) mice (n = 4) were tested. The OVX group that received treatment underwent weekly sessions for 4 weeks, during which they were exposed to low-intensity pulsed ultrasound (LIPUS) stimulation following administration of NB-CTSK siRNA-AL, prior to being sacrificed. Both groups underwent a series of tests to evaluate the bone targeting, safety, and efficacy of the nanoplatform. These tests included biodistribution studies conducted at 4 h and 24 h post-injection, a 3-point bending test of the femurs, nano-computed tomography analysis, as well as Hematoxylin & Eosin histological staining, Masson's Trichrome staining, and CTSK staining. The biodistribution showed the accumulation of NB-CTSK siRNA-AL in the bone and liver. Results showed that the OVX mice treated with NB-CTSK siRNA-AL had increased distal cortical bone thickness (174.4 ± 5.28 μm vs. 144.3 ± 10.66 μm, p > 0.05)) and bone volume fraction (16.5 ± 3.96 % vs. 6.55 ± 0.13 % (p > 0.05)). A reduced collagen degradation and downregulated CTSK expression were evident in the staining procedures. No adverse effects were recorded within histological assessments on the liver, kidney, and heart post-treatment. Morphology was shown to be normal and healthy within muscle cells post-LIPUS stimulation of NB-CTSK siRNA-AL. From these results, it can be concluded that an ultrasound-mediated NB-CTSK siRNA-AL can serve as a reliable, safe CTSK siRNA carrier to bone-specific targets for in vivo osteoporosis treatment.

Fluoroamphiphiles for enhancing immune response of subunit vaccine against SARS-CoV-2

In recent decades, protein-based therapy has garnered valid attention for treating infectious diseases, genetic disorders, cancer, and other clinical requirements. However, preserving protein-based drugs against degradation and denaturation during processing, storage, and delivery poses a formidable challenge. Herein, we designed a novel fluoroamphiphiles polymer to deliver protein. Two different formulations of nanoparticles, cross-linked (CNP) and micelle (MNP) polymer, were prepared rationally by disulfide cross-linked and thin-film hydration techniques, respectively. The size, zeta potential, and morphology of both formulations were characterized and the delivery efficacy of both in vitro and in vivo was also assessed. The in vitro findings demonstrated that both formulations effectively facilitated protein delivery into various cell lines. Moreover, in vivo experiments revealed that intramuscular administration of the two formulations loaded with a SARS-CoV-2 recombinant receptor-binding domain (RBD) vaccine induced robust antibody responses in mice without adding another adjuvant. These results highlight the potential use of our carrier system as a safe and effective platform for the in vivo delivery of subunit vaccines.

Improving ammonia oxidation to nitrogen across wide potential range via synergistic effect over Cu and Ni anchored Metal‐Organic Frameworks

Ammonia is a safe and efficient hydrogen carrier, and electrocatalytic ammonia oxidation reaction (AOR) is a pivotal anodic process for ammonia decomposition to produce hydrogen. Although previous works have devoted to reducing the reaction potential, concurrently achieving a high Faradaic efficiency (FE) for nitrogen (N2) remains a substantial challenge, particularly across a broad potential range. Here, Ni and Cu nanoparticles anchored nickel metal–organic framework (Ni-NDC) electrocatalyst is successfully synthetized. During the AOR process, the surface catalyst could be evolved into stable NiOOH. The well-dispersed Ni and Cu nanoparticles on the Ni-NDC facilitate a unique interaction between Cu and both the Ni nanoparticles and the Ni-NDC framework. With the incorporation of Cu, the adsorption of hydroxyl (*OH) is impaired to suppress the formation of oxygen-containing by-products (such as NO3– and NO2–) across a wide potential range. Consequently, the FE(N2) is markedly high (approximately 90%). Additionally, the reaction kinetic is also improved, resulting in a lower reaction potential for AOR. This work provides an effective method for synthesizing high-performance AOR electrocatalysts.

Polysaccharide Based Self-Driven Tubular Micro/Nanomotors as a Comprehensive Platform for Quercetin Loading and Anti-inflammatory Function.

Quercetin (QR) is a natural flavonoid with strong anti-inflammatory properties, but it suffers from poor water solubility and bioavailability. Micro/nanomotors (NMs) are tiny devices that convert external energy or chemical fuels into an autonomous motion. They are characterized by their small size, rapid movement, and self-assembly capabilities, which can enhance the delivery of bioactive ingredients. The study synthesized natural polysaccharide-based nanotubes (NTs) using a layer-by-layer self-assembly method and combined with urease (Ure), glucose oxidase (GOx), and Fe3O4 to create three types of NMs. These NMs were well-dispersed and biocompatible. In vitro experiments showed that NMs-Fe3O4 has excellent photothermal conversion properties and potential for use in photothermal therapy. Cellular inflammation model results demonstrated that QR-loaded NMs were not only structurally stable but also improved bioavailability and effectively inhibited the release of inflammatory mediators such as IL-1β and IL-6, providing a safe and advanced carrier system for the effective use of bioactive components in food.

Visible-Light-Induced Hydrogen Generation from Mixtures of Hydrogen Boride Nanosheets and Phenanthroline Molecules.

Hydrogen boride (HB) nanosheets are recognized as a safe and lightweight hydrogen carrier, yet their hydrogen (H2) generation technique has been limited. In the present study, nitrogen-containing organic heterocycles are mixed with HB nanosheets in acetonitrile solution for visible-light-driven H2 generation. After exploring various nitrogen-containing heterocycles, the mixture of 1,10-phenanthroline molecules (Phens) and HB nanosheets exhibited significant H2 generation even under visible light irradiation. The quantum efficiency for H2 generation of the mixture of HB nanosheets and Phens is 0.6%. Based on spectroscopic and electrochemical analyses and density functional theory (DFT) calculations, it is determined that radical species generated from Phens with electrons and protons donated by HB nanosheets are responsive to visible light for H2 generation. The HB nanosheets/Phens mixture presented in this study can generate H2 using renewable energy sources such as sunlight without the need for complex electrochemical systems or heating mechanisms and is expected to serve as a lightweight hydrogen storage/release system.

Preparation of ceftiofur-encapsulated hen-egg low-density lipoproteins and their antibacterial effects on intracellular Staphylococcus aureus

Hen egg low-density lipoprotein (heLDL), as alternative of serum-derived LDL, was used as drug delivery system of ceftiofur (CEF). The CEF-loaded hen egg low-density lipoprotein (CEF-heLDL) with complete apolipoprotein structure and high drug loading rate was synthesized, possesses suitable particle size. CEF-heLDL undergoes cellular uptake and colocalizes with lysosomes in vitro. An intracellular infection model of the bovine endometrial epithelial cells and a coeliac-induced inflammation model of mice by Staphylococcus aureus (S. aureus) were established, and significantly lower intracellular S. aureus levels of CEF-heLDL group than CEF-free group (P < 0.001) was observed. The antibacterial efficacy was sustained for 24 h. Up to 400 mg/kg of CEF-heLDL, 20 times the clinical practice, were intraperitoneally administrated, and no significant toxicity signs on mice were observed. HeLDLs is an effective, safe, and cheap drug carrier, and could also be used for transmembrane delivering other antibiotics.

Process intensification in the continuous dehydrogenation of methylcyclohexane to toluene

The toluene/methylcyclohexane cycle is a safe and practical Liquid Organic Hydrogen Carrier (LOHC) for the storage of hydrogen. Nevertheless, the dehydrogenation reaction of methylcyclohexane (MCH) should be improved to assure a total selectivity to toluene (TOL), avoiding the subproducts formation. In this research, a millireactor with channel internal diameter in the range of milimeters has been tested and evaluated in the dehydrogenation of MCH to TOL. The millireactor configuration confers it some features and advantages compared to fixed-bed reactors, e.g., better mass and energy transfer and increased performance (10–20 %). To verify these advantages, a comparison between conventional fixed bed (9 mm i.d.) and millireactor is carried out. Thanks to its configuration, the millireactor could control effectively the heat generated by the reactions to avoid hot-spot formation and the sintering of the catalyst. The results obtained demonstrate that the catalysts activity in the reaction is improved with the application of the millireactor respect the fixed-bed ones and neither catalyst sintering, nor pressure drop was appreciated during the catalytic tests. At the best reaction conditions, Tecnalia´s millireactor converses continuously up to 99 % of MCH to TOL with 100 % selectivity at atmospheric pressure, showing the huge potential of the millireactor concept.

Engineered Exosomes for Drug Delivery in Cancer Therapy: A Promising Approach and Application.

A significant amount of research effort is currently focused on investigating the role of exosomes in various cancers. These tiny vesicles, apart from acting as biomarkers, also play a crucial role in tumor formation and development. Several studies have demonstrated that exosomes can be a drug delivery vehicle for cancer therapy. In this paper, we highlight the key advantages of exosomes as a drug delivery candidate, with a particular focus on their low immunogenicity, natural targeting ability and suitable mechanical properties. Furthermore, we propose that the selection of appropriate exosomes and drug loading methods based on therapeutic goals and product heterogeneity is essential for preparing engineered exosomes. We comprehensively analyzed the superiorities of current drug-loading methods to improve the creation of designed exosomes. Moreover, we systematically review the applications of engineered exosomes in various therapies such as immunotherapy, gene therapy, protein therapy, chemotherapy, indicating that engineered exosomes have the potential to be reliable and, safe drug carriers that can address the unmet needs in cancer clinical practice.

Visible-Light-Driven Hydrogen Release from Dye-Sensitized Hydrogen Boride Nanosheets.

Hydrogen boride (HB) nanosheets are expected to be safe and lightweight hydrogen carriers because of their high gravimetric hydrogen density (8.5 wt %) and photon-driven hydrogen release under mild conditions. However, previously reported HB nanosheets respond only to ultraviolet (UV) light to release hydrogen. In this study, we develop dye-modified HB nanosheets that can release hydrogen under visible light irradiation (>470 nm) without heat input. Hydrogen generation is initiated by electron injection from excited dye molecules into the conduction band of the HB nanosheets. The conduction band of the HB nanosheets is formed by the antibonding states of the B 2py and H 1s atomic orbitals, and the electrons injected from the dye molecules react with the protons of the HB nanosheets to release gaseous hydrogen molecules. Although the hydrogen production is terminated after long-term light irradiation owing to dye oxidation and/or loss of protons in HB nanosheets, the total amount of the released hydrogen molecules corresponds to approximately 25% of the protons in HB nanosheets even under the extra mild conditions. The addition of a sacrificial agent like iodine ions and a proton source like formic acid sustained the H2 generation from the dye-modified HB nanosheets under visible light irradiation for long term.

SAPPα Peptide Promotes Damaged Microglia to Clear Alzheimer's Amyloid-β via Restoring Mitochondrial Function.

Alzheimer's disease (AD) is an age-related neurodegenerative disease with amyloid-β (Aβ) deposition as the main pathological feature. It's an important challenge to find new ways to clear Aβ from the brain. The soluble amyloid precursor protein α (sAPPα) is a neuroprotective protein and can attenuate neuronal damage, including toxic Aβ. However, the regulatory role of sAPPα in non-neuronal cells, such as microglia, is less reported and controversial. Here, we showed that sAPPα promoted the phagocytosis and degradation of Aβ in both normal and damaged microglia. Moreover, the function of damaged microglia was improved by the sAPPα through normalizing mitochondrial function. Furthermore, the results of molecular docking simulation showed that sAPPα had a good affinity with Aβ. We preliminarily reveal that sAPPα is similar to antibodies and can participate in the regulation of microglia phagocytosis and degradation of Aβ after binding to Aβ. sAPPα is expected to be a mild and safe peptide drug or drug carrier for AD.

Mouldable Collagen-Tricalciumphosphate Is a Safe Carrier for Local Antibiotics-Short-Term Results in Revision Hip Arthroplasty.

Improving local antibiotic delivery is a promising approach to improve infection control and potentially shorten systemic treatment in periprosthetic joint infection (PJI). This study investigates the use of an antibiotic-loaded, mouldable collagen-tricalciumphosphate composite in treatment of hip PJI. 124 application cases in 79 patients were included from a referral centre; systemic adverse infects, local complications, and infection control were analysed. In most cases, either vancomycin or meropenem were used. Pathogens were previously known in 82 (66%) cases with polymicrobial infection in 20 (25%) patients. There were no cases of hypercalcaemia. Acute kidney injure was present in 14 (11%) cases. Chronic kidney failure persisted in two cases. During a mean follow-up of 12 (SD 9.3; range 3-35) months, implant survival was achieved in 73 (92%) patients; revision due to PJI was performed in 19 cases. Mouldable collagen-tricalciumphosphate composite bone substitute as a local antibiotic carrier in revision hip arthroplasty appears to be a valid option for local antibiotic delivery without systemic complications. Implant survival of 92% supports the hypothesis that local antibiotic therapy is an important component in the treatment of PJI.

The anti-cancer properties of miR-340 plasmid-chitosan complexes (miR-340 CC) on murine model of breast cancer*

MiRNA-340 (miR-340) has been found to have tumour-suppressing effects in breast cancer (BC). However, for clinical use, miRNAs need to be delivered safely and effectively to protect them from degradation. In our previous study, we used chitosan complexes as a safe carrier with anti-cancer properties to deliver miR-340 plasmid into 4T1 cells. This study explored further information concerning the anti-cancer impacts of both chitosan and miR-340 plasmid in a murine model of BC. Mice bearing 4T1 cells were intra-tumorally administered miR-340 plasmid-chitosan complexes (miR-340 CC). Afterwards, the potential of miR-340 CC in promoting anti-tumour immune responses was evaluated. MiR-340 CC significantly reduced tumour size, inhibited metastasis, and prolonged the survival of mice. MiR-340 CC up-regulates P-27 gene expression related to cancer cell apoptosis, and down-regulates gene expressions involved in angiogenesis and metastasis (breast regression protein-39 (BRP-39)) and CD163 as an anti-inflammatory macrophages (MQs) marker. Furthermore, CD47 expression as a MQs immune check-point was remarkably decreased after miR-340 CC treatment. The level of IL-12 in splenocytes of miR-340 CC treated mice increased, while the level of IL-10 decreased, indicating anti-cancer immune responses. Our findings display that miR-340 CC can be considered as a promising therapy in BC.

Synthesis and Catalytic Performance of Mo2C/MoS2 Composite Heterojunction Catalysts.

Hydrogen, as a clean, safe, and efficient energy carrier, is one of the hot energy sources that have attracted much attention. Mo2C, due to the introduction of C atoms, makes the atomic spacing of the Mo lattice decrease and changes the width of the d-band, which makes the electronic properties of Mo2C similar to that of Pt noble metals, exhibiting excellent electrochemical hydrogen precipitation performance. MoS2, due to its special crystal structure and tunable electronic structure, has been widely studied. In this paper, Mo2C nanoparticles were prepared by high-temperature carbonization, and then two-dimensional layered MoS2 were be loaded on Mo2C nanoparticles by the hydrothermal method to synthesize Mo2C/MoS2 composite catalysts. Their electrochemical hydrogen precipitation (HER) performance under acidic conditions was tested. The above catalysts were also characterized by modern material testing methods such as XRD, SEM, TEM, and XPS. The results showed that the composite catalysts exhibited the most excellent electrochemical hydrogen precipitation performance at Mo2C/MoS2-3, with the lowest overpotential at a current density of 10 mA cm-2, Tafel slope, and electrochemical impedance. At the same time, the electrochemically active area was dramatically enhanced, with good stability under prolonged testing. The catalytic activity was significantly improved compared with that of Mo2C and MoS2. The characterization and experimental results indicate that the heterogeneous structure of Mo2C and MoS2 formed a built-in electric field between the two, which accelerated the electron transfer efficiency and provided more active sites. The Mo2C/MoS2 composite catalyst is a low-cost, easy-to-prepare, and high-efficiency electrochemical hydrogen precipitation catalyst, providing a new idea for developing green and clean energy.